Bellerophon Therapeutics Stock Price, News & Analysis

BLPH OTC

Company Description

Welcome to the overview page for Bellerophon Therapeutics (BLPH), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$0.0

12.2M

Shares outstanding

Latest News

June 5, 2023

86.64%

Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease

clinical trial

May 15, 2023

19.29%

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

earnings

May 11, 2023

2.43%

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

clinical trial

March 31, 2023

5.76%

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

earnings

March 6, 2023

94.10%

Bellerophon Therapeutics Announces $5 Million Registered Direct Offering

offering

February 9, 2023

9.64%

Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease

clinical trial

SEC Filings

No SEC filings available for Bellerophon Therapeutics.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Bellerophon Therapeutics (BLPH)?

The current stock price of Bellerophon Therapeutics (BLPH) is $0.0545 as of April 16, 2024.